SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 86.46 |
| Enterprise Value ($M) | 19.05 |
| Book Value ($M) | 75.80 |
| Book Value / Share | 2.50 |
| Price / Book | 1.14 |
| NCAV ($M) | 74.08 |
| NCAV / Share | 2.44 |
| Price / NCAV | 1.17 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.28 |
| Return on Assets (ROA) | -1.78 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 14.19 |
| Current Ratio | 14.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 79.81 |
| Assets | 81.54 |
| Liabilities | 5.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | 5AM Partners VII, LLC | 36.40 | -1.74 | |
| 13G/A | Janus Henderson Group Plc | 0.00 | -100.00 | |
| 13G/A | Altium Capital Management LP | 4.30 | 1.05 | |
| 13G | Sphera Funds Management Ltd. | 5.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 47,503 | 279,389 | 17.00 | |
| 36,646 | 157,268 | 23.30 | |
| 30,024 | 119,556 | 25.11 | |
| 37,211 | 124,927 | 29.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SCYX – SCYNEXIS, Inc. | SGMT – Sagimet Biosciences Inc. |
| SIGA – SIGA Technologies, Inc. | SMMT – Summit Therapeutics Inc. |
| SPRY – ARS Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io